Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
1.030
-0.080 (-7.21%)
At close: Nov 7, 2024, 4:00 PM
1.080
+0.050 (4.85%)
After-hours: Nov 7, 2024, 6:07 PM EST

Carisma Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-72.5-86.88-61.23-40.78-28.35
Depreciation & Amortization
3.372.841.890.680.45
Other Amortization
-1.282.54--
Loss (Gain) From Sale of Assets
0.160.16---
Loss (Gain) From Sale of Investments
-0.54-1.11---
Stock-Based Compensation
3.42.320.280.480.16
Other Operating Activities
7.545.656.210.831.18
Change in Accounts Payable
-0.372.19-0.47-0.971.28
Change in Unearned Revenue
-4.51-1.0547.46--
Change in Other Net Operating Assets
-12.26-6.58-1.792.44-1.74
Operating Cash Flow
-75.64-81.18-5.12-37.33-27.01
Capital Expenditures
-0.87-1.13-4.66-1.87-0.44
Investment in Securities
4173.54-27.9--
Investing Cash Flow
40.1372.41-32.56-1.87-0.44
Long-Term Debt Issued
-1.1836.63--
Long-Term Debt Repaid
--2.37-0.96--
Net Debt Issued (Repaid)
-2.77-1.1935.66--
Issuance of Common Stock
3.0231.420.11-0.02
Other Financing Activities
-0.7631.94-2.45-0.37-
Financing Cash Flow
-0.5162.1833.3215.9672.26
Net Cash Flow
-36.0253.41-4.36-23.2444.81
Free Cash Flow
-76.51-82.31-9.78-39.2-27.45
Free Cash Flow Margin
-369.45%-551.71%-99.41%--
Free Cash Flow Per Share
-1.87-2.46-4.59-36.16-25.82
Cash Interest Paid
0.370.350.1--
Levered Free Cash Flow
-46.39-51.52-30.1-24.24-
Unlevered Free Cash Flow
-46.39-52.8-30.68-24.24-
Change in Net Working Capital
4.811.37-6.92-1.97-
Source: S&P Capital IQ. Standard template. Financial Sources.